|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/5025 | |||
| A61P 3/04 |
| (11) | Number of the document | 1848749 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06734512.4 |
| Date of filing the European patent application | 2006-02-03 | |
| (97) | Date of publication of the European application | 2007-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/004306 |
| Date | 2006-02-03 |
| (87) | Number | WO 2006/084275 |
| Date | 2006-08-10 |
| (30) | Number | Date | Country code |
| 650450 P | 2005-02-04 | US | |
| 692049 P | 2005-06-17 | US | |
| 736140 P | 2005-11-10 | US | |
| 346770 | 2006-02-03 | US |
| (72) |
BYRNE, Mark, E., US
VENKATESM, Siddarth, US
|
| (73) |
Auburn University,
215 East Thach Avenue, Auburn, AL 36830,
US
|
| (54) | Contact drug delivery system |
| Contact drug delivery system |